The Butantan Institute: History and Future Perspectives

DR do Nascimento, 2011, [The arrival of the plague in Sao Paulo in 1899], Dynamis, 31, 65

V BRAZIL, 1950, [Contribution to the study of venom glands of aglyphous snakes], An Paul Med Cir, 60, 463

BJ Hawgood, 1999, Doctor Albert Calmette 1863–1933: founder of antivenomous serotherapy and of antituberculous BCG vaccination, Toxicon, 37, 1241, 10.1016/S0041-0101(99)00086-0

BJ Hawgood, 1992, Pioneers of anti-venomous serotherapy: Dr Vital Brazil (1865–1950), Toxicon, 30, 573, 10.1016/0041-0101(92)90851-U

BJ Hawgood, 2001, Karl Heinrich Slotta (1895–1987) biochemist: snakes, pregnancy and coffee, Toxicon, 39, 1277, 10.1016/S0041-0101(00)00264-6

EN Miyaji, 2013, Serotype-independent pneumococcal vaccines, Cell Mol Life Sci, 70, 3303, 10.1007/s00018-012-1234-8

E Carvalho, 2012, Breaking the bond: recent patents on bacterial adhesins, Recent Pat DNA Gene Seq, 6, 160, 10.2174/187221512801327352

HG Higashi, 2009, Acellular and “low” pertussis vaccines: adverse events and the role of mutations, Rev Inst Med Trop Sao Paulo, 51, 131, 10.1590/S0036-46652009000300002

W Quintilio, 2009, Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice, Vaccine, 27, 4219, 10.1016/j.vaccine.2009.04.047

AL Nascimento, 2004, Genome features of Leptospira interrogans serovar Copenhageni, Braz J Med Biol Res, 37, 459, 10.1590/S0100-879X2004000400003

S Lucas, 1988, Spiders in Brazil, Toxicon, 26, 759, 10.1016/0041-0101(88)90317-0

WD da Silva, 2011, The humoral immune response induced by snake venom toxins, Inflamm Allergy Drug Targets, 10, 343, 10.2174/187152811797200623

MF Furtado, 2010, Antigenic cross-reactivity and immunogenicity of Bothrops venoms from snakes of the Amazon region, Toxicon, 55, 881, 10.1016/j.toxicon.2009.12.014

GP Queiroz, 2008, Interspecific variation in venom composition and toxicity of Brazilian snakes from Bothrops genus, Toxicon, 52, 842, 10.1016/j.toxicon.2008.10.002

P Saravia, 2002, Geographic and ontogenic variability in the venom of the neotropical rattlesnake Crotalus durissus: pathophysiological and therapeutic implications, Rev Biol Trop, 50, 337

OA Sant'Anna, 2007, Immunology in Brazil: historical fragments, Scand J Immunol, 66, 106, 10.1111/j.1365-3083.2007.01960.x

SM Serrano, 2013, The long road of research on snake venom serine proteinases, Toxicon, 62, 19, 10.1016/j.toxicon.2012.09.003

AC Camargo, 2012, Bradykinin-potentiating peptides: beyond captopril, Toxicon, 59, 516, 10.1016/j.toxicon.2011.07.013

Y Cury, 2011, Pain and analgesia: The dual effect of nitric oxide in the nociceptive system, Nitric Oxide, 25, 243, 10.1016/j.niox.2011.06.004

AM Tanaka-Azevedo, 2010, Thrombin inhibitors from different animals, J Biomed Biotechnol, 2010, 641025

DV Tambourgi, 2010, Loxoscelism: From basic research to the proposal of new therapies, Toxicon, 56, 1113, 10.1016/j.toxicon.2010.01.021

SC Sampaio, 2010, Crotoxin: novel activities for a classic beta-neurotoxin, Toxicon, 55, 1045, 10.1016/j.toxicon.2010.01.011

SW Dias da, 2010, IgY: a promising antibody for use in immunodiagnostic and in immunotherapy, Vet Immunol Immunopathol, 135, 173, 10.1016/j.vetimm.2009.12.011

AM Moura-da-Silva, 2007, Importance of snake venom metalloproteinases in cell biology: effects on platelets, inflammatory and endothelial cells, Curr Pharm Des, 13, 2893, 10.2174/138161207782023711

PL Ho, 2011, Economical value of vaccines for the developing countries–the case of Instituto Butantan, a public institution in Brazil, PLoS Negl Trop Dis, 5, e1300, 10.1371/journal.pntd.0001300

C Miyaki, 2011, Influenza vaccine production for Brazil: a classic example of successful North-South bilateral technology transfer, Vaccine, 29, A12, 10.1016/j.vaccine.2011.04.127

I Valencia, 2013, Phacilitate, Partnering for Vaccine Emerging Markets: June 10–11 2013, Berlin, Hum Vaccin Immunother, 9, 2019, 10.4161/hv.25946